Home › Pancreatic Cancer › NCT07817147
CREO - Microwave Ablation Feasibility Study
Investigator-Initiated Feasibility Study of a Novel Endoscopic Ultrasound Guided Microwave Ablation Device in Patients With Locally Advanced, Unresectable, or Metastatic Cancer
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Male or female ≥18 years of age * Willing and able to provide written informed consent * Histologically confirmed locally advanced, unresectable or metastatic cancer (Stage III or IV) * At least 1 tumor that is indicated for MWA, and the location of target tumor must be accessible via EUS through the gastric wall (eg, pancreas, liver, etc). * The tumor(s) must be ≥1 cm in diameter Exclusion Criteria: * Participant is a candidate for upfront resection of pancreatic cancer * Participation in another clinical trial that involves local ablation or any other local therapy that could affect the target organ or lesions treated in this study * Any condition that, in the opinion of the investigator, may increase the risk to the participant's safety or well-being
About the study
The goal of this study is to assess the overall success of energy delivery during treatment using the ultrasound guided microwave ablation device in patients with locally advanced, unresectable, or metastatic cancer. Secondly, this study aims to explore the procedural/clinical safety of treatment with the device and the antitumor effect following treatment with the device.
What is being tested
- EUS-Guided MWA Device (device)
Sponsor: Banner Health · Participants: 75 · Started: Feb 19, 2026
Contact the study team
- Neil Sharma, MD · Phone: (480) 356 - 6444
Official record on ClinicalTrials.gov — NCT07817147
Locations in the U.S.
| Arizona | Banner MD Anderson Cancer Center and Gateway Hospital, Gilbert |
| California | Cedars Sinai, Los Angeles (Not yet recruiting) |
| Illinois | Rush University Medical Center, Chicago (Not yet recruiting) |
| Minnesota | Mayo Clinic Rochester, Rochester (Not yet recruiting) |
| Tennessee | University of Tennessee Medical, Knoxville (Not yet recruiting) |
| Texas | Memorial Hermann-Texas Medical Center, Houston (Not yet recruiting) |
| West Virginia | West Virginia University Medicine, Morgantown (Not yet recruiting) |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.